Anatomy, Function, and Dysfunction of the Right Ventricle: JACC State-of-the-Art Review

J Sanz, D Sánchez-Quintana, E Bossone… - Journal of the American …, 2019 - jacc.org
There is increasing recognition of the crucial role of the right ventricle (RV) in determining
functional status and prognosis in multiple conditions. The normal RV is anatomically and …

Pulmonary arterial hypertension: pathogenesis and clinical management

T Thenappan, ML Ormiston, JJ Ryan, SL Archer - Bmj, 2018 - bmj.com
Pulmonary hypertension is defined as a resting mean pulmonary artery pressure of 25 mm
Hg or above. This review deals with pulmonary arterial hypertension (PAH), a type of …

The right ventricle in pulmonary arterial hypertension: disorders of metabolism, angiogenesis and adrenergic signaling in right ventricular failure

JJ Ryan, SL Archer - Circulation research, 2014 - Am Heart Assoc
The right ventricle (RV) is the major determinant of functional state and prognosis in
pulmonary arterial hypertension. RV hypertrophy (RVH) triggered by pressure overload is …

Right ventricular adaptation and failure in pulmonary arterial hypertension

JJ Ryan, J Huston, S Kutty, ND Hatton… - Canadian Journal of …, 2015 - Elsevier
Pulmonary arterial hypertension (PAH) is an obstructive pulmonary vasculopathy,
characterized by excess proliferation, apoptosis resistance, inflammation, fibrosis, and …

World Health Organization Group I pulmonary hypertension: epidemiology and pathophysiology

KW Prins, T Thenappan - Cardiology clinics, 2016 - cardiology.theclinics.com
Pulmonary hypertension (PH) is defined as mean pulmonary arterial pressure(PAP)
measured by right heart catheterization of 25 mm Hg or higher at rest. 1 The most recent …

Emerging concepts in the molecular basis of pulmonary arterial hypertension: part I: metabolic plasticity and mitochondrial dynamics in the pulmonary circulation and …

JJ Ryan, SL Archer - Circulation, 2015 - Am Heart Assoc
Mitochondria are central to cellular metabolism. The metabolic pathways of mitochondria
include fatty acid oxidation, glucose oxidation, and glutaminolysis. The initial step in glucose …

A comprehensive review: the evolution of animal models in pulmonary hypertension research; are we there yet?

G Maarman, S Lecour, G Butrous… - Pulmonary …, 2013 - journals.sagepub.com
Pulmonary hypertension (PH) is a disorder that develops as a result of remodeling of the
pulmonary vasculature and is characterized by narrowing/obliteration of small pulmonary …

Mitochondrial dynamics in pulmonary arterial hypertension

J Ryan, A Dasgupta, J Huston, KH Chen… - Journal of molecular …, 2015 - Springer
Pulmonary arterial hypertension (PAH) is an idiopathic cardiopulmonary disease
characterized by obstruction of small pulmonary arteries. Vascular obstruction is the …

Dynamic and diverse changes in the functional properties of vascular smooth muscle cells in pulmonary hypertension

KR Stenmark, MG Frid, BB Graham… - Cardiovascular …, 2018 - academic.oup.com
Pulmonary hypertension (PH) is the end result of interaction between pulmonary vascular
tone and a complex series of cellular and molecular events termed 'vascular remodelling' …

Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle's cycle

YH Fang, L Piao, Z Hong, PT Toth, G Marsboom… - Journal of molecular …, 2012 - Springer
Right ventricular hypertrophy (RVH) and RV failure are major determinants of prognosis in
pulmonary hypertension and congenital heart disease. In RVH, there is a metabolic shift …